rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCACGGTCATTGCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	0.06325301204819277		47	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-02	01	7	2	7	4	18	0	18	28	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01		TCRBJ01-02*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGCAACCTCTCAGCAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	0.060240963855421686		56	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	15	5	25	37	56	52	61		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
GACTCGGCCRTGTATSKCTGTGCCAGCATGACGCAGTCGGCACGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	0.060240963855421686		56	unresolved						TCRBJ01	TCRBJ01-02	01	7	2	7	4	1	26	18	28	32	29	58	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	0.07228915662650602		47	TCRBV03						TCRBJ02	TCRBJ02-01	01	2	4	6	5	2	11	26	41	45	43	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCCCCGGGGGGGCTAAGAACCGGGGAGCTGTTTTTTGGAGAA	CATSPGGLRTGELFF	In	VDJ	1	34	0.10240963855421686	0.24113475177304963	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	8	0	5	4	6	24	33	45	37	51		TCRBV24-01,TCRBV24-or09_02												CATSPGGLRTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
TCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTAATAAAGGTGGGTGCTACAAAGTCGGGCCAACGTCTGACTTTCGGGGCC		Out	VDJ	1	28	0.08433734939759036		56	TCRBV06	unresolved					TCRBJ02	TCRBJ02-06	01	3	8	0	16	23	6	23	37	64	60	70		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATAGTCTAGGACAGGGAACTTCACCCCTCCACTTTGGGAAC	CASSQDSLGQGTSPLHF	In	VDJ	1	25	0.07530120481927711	0.1773049645390071	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	3	9	7	3	23	40	55	47	58													Vb 7.1	CASSQDSLGQGTSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCGAAACAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSETGQSRANVLTF	In	VDJ	1	41	0.12349397590361445	0.2907801418439716	48	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	6	5	22	34	45	40	50														CASSETGQSRANVLTF+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTAAGTTGAAGGTGTAGCCATAGGTCTTTCCACACCTTCGGTTCG	CATSVS*RCSHRSFHTF	Stop	VDJ	1	58	0.1746987951807229		51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	7	12	14	13	18	30	48	44	61						01,02								CATSVS*RCSHRSFHTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
GAGACACGGCACTGTATCTCTGCGCCAGTAAACCACCAGGGACGGGATCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	0.060240963855421686		44	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	9	0	7	4	10	5	20	28	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGACTACCACGAGCAGTACTTCGGGCCG	CASSDDYHEQYF	In	VDJ	1	15	0.045180722891566265	0.10638297872340426	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	9	5	3	2	23	35	43	38	45						01,02								CASSDDYHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATCGACAGGGACGATTTATGGCTACACCTTCGGTTCG	CASSPSTGTIYGYTF	In	VDJ	1	26	0.0783132530120482	0.18439716312056736	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	5	5	6	23	35	47	40	53														CASSPSTGTIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4997A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				12	5	4	2	0	12	5	6	1	0	332	141	133	58	0	0.0313376337	2.24916434	0.0295757763	3.47893453				171	0.0489347838	0.290780127	0.1746988	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:56	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1743,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 536,type of chemo:carbo/taxol	0.41666665530982433	MSKCC- Snyder- P01-02		8.0	
